General information | DisProt: | DP00339 | Name: | Histo-blood group A transferase | Synonym(s): | BGAT_HUMAN
NAGAT
Glycoprotein-fucosylgalactoside alpha-N-acetylgalactosaminyltransferase
EC=2.4.1.40
Fucosylglycoprotein alpha-N-acetylgalactosaminyltransferase
Transferase A
GTA
Fucosylglycoprotein alpha-N-acetylgalactosaminyltransferase soluble form [cleavage product 1]
| First appeared in release: | Release 3.0 (02/17/2006) | UniProt: | P16442 | UniGene: | Hs.654423 | SwissProt: | BGAT_HUMAN | TrEMBL: | | NCBI (GI): | 114949 | Source organism: | Homo sapiens (Human) | Sequence length: | 354 | Percent disordered: | 7% | Homologues: | |
Native sequence |
10 20 30 40 50 60 | | | | | | MAEVLRTLAG KPKCHALRPM ILFLIMLVLV LFGYGVLSPR SLMPGSLERG FCMAVREPDH - 60 LQRVSLPRMV YPQPKVLTPC RKDVLVVTPW LAPIVWEGTF NIDILNEQFR LQNTTIGLTV - 120 FAIKKYVAFL KLFLETAEKH FMVGHRVHYY VFTDQPAAVP RVTLGTGRQL SVLEVRAYKR - 180 WQDVSMRRME MISDFCERRF LSEVDYLVCV DVDMEFRDHV GVEILTPLFG TLHPGFYGSS - 240 REAFTYERRP QSQAYIPKDE GDFYYLGGFF GGSVQEVQRL TRACHQAMMV DQANGIEAVW - 300 HDESHLNKYL LRHKPTKVLS PEYLWDQQLL GWPAVLRKLR FTAVPKNHQA VRNP
|
Functional narrative |
This protein is the basis of the ABO blood group system. The histo-blood group ABO involves three carbohydrate antigens: A, B, and H. A, B, and AB individuals express a glycosyltransferase activity that converts the H antigen to the A antigen (by addition of UDP-GalNAc) or to the B antigen (by addition of UDP-Gal), whereas O individuals lack such activity.
|
Map of ordered and disordered regions |
Note: 'Mouse' over a region to see the start and stop residues. Click on a region to see detailed information.
|
Region 1 | Type: | Disordered | Name: | | Location: | 179 - 194 | Length: | 16 | Region sequence: |
KRWQDVSMRRMEMISD | Modification type: | Fragment
Monomeric
Native
| PDB: | 1LZ0:A | Structural/functional type: | Function arises from the disordered state | Functional classes: | Unknown
| Functional subclasses: | Autoregulatory
| Detection methods:
- X-ray crystallography (291 K; pH: 7.5; 3-chloro-Hg-2-methoxy-propylurea (0.3 - 0.5 mM); ADA (pH 7.5, 70 mM); Glycerol (5%); Maganese chloride (5 - 8 mM); MPD (2.5%); PEG 4000 (2%); Sodium acetate (pH 4.6, 50 mM); Sodium chloride (40 mM))
| References:
- Patenaude SI, Seto NO, Borisova SN, Szpacenko A, Marcus SL, Palcic MM, Evans SV. "The structural basis for specificity in human ABO(H) blood group biosynthesis." Nat Struct Biol. 2002; 9(9): 685-90. PubMed: 12198488
- Yazer MH, Denomme GA, Rose NL, Palcic MM. "Amino-acid substitution in the disordered loop of blood group B-glycosyltransferase enzyme causes weak B phenotype." Transfusion. 2005; 45(7): 1178-82. PubMed: 15987364
| Comments:The GTA catalytic domain (residues 63 - 354) was used for the crystallization studies, which is the soluble form of the protein.
It is thought that the disordered loop may play a role in regulating the catalytic activity of the enzyme, however, it is not clear if the regulation occurs during substrate binding or product release.
Unlike glycosyltransferases found in other organisms, the disordered loop does not become ordered upon substrate binding.
|
Region 2 | Type: | Disordered | Name: | | Location: | 345 - 354 | Length: | 10 | Region sequence: |
PKNHQAVRNP | Modification type: | Fragment
Monomeric
Native
| PDB: | 1LZ0:A | Structural/functional type: | Relationship to function unknown | Functional classes: | Unknown
| Functional subclasses: | Unknown
| Detection methods:
- X-ray crystallography (291 K; pH: 7.5; 3-chloro-Hg-2-methoxy-propylurea (0.3 - 0.5 mM); ADA (pH 7.5, 70 mM); Glycerol (5%); Maganese chloride (5 - 8 mM); MPD (2.5%); PEG 4000 (2%); Sodium acetate (pH 4.6, 50 mM); Sodium chloride (40 mM))
| References:
- Patenaude SI, Seto NO, Borisova SN, Szpacenko A, Marcus SL, Palcic MM, Evans SV. "The structural basis for specificity in human ABO(H) blood group biosynthesis." Nat Struct Biol. 2002; 9(9): 685-90. PubMed: 12198488
- Yazer MH, Denomme GA, Rose NL, Palcic MM. "Amino-acid substitution in the disordered loop of blood group B-glycosyltransferase enzyme causes weak B phenotype." Transfusion. 2005; 45(7): 1178-82. PubMed: 15987364
| Comments:
|
References |
- Yamamoto F, Clausen H, White T, Marken J, Hakomori S. "Molecular genetic basis of the histo-blood group ABO system." Nature. 1990; 345(6272): 229-33. PubMed: 2333095
- Yamamoto F, Hakomori S. "Sugar-nucleotide donor specificity of histo-blood group A and B transferases is based on amino acid substitutions." J Biol Chem. 1990; 265(31): 19257-62. PubMed: 2121736
|
Comments |
A separate entry may be required for cleavage product 1.
|
If you have any comments or wish to provide additional references to this protein or its disordered region(s), please click here to e-mail us. |
Disprot-footer
|